Alnylam Pharmaceuticals <ALNY.O>: BofA Global Research cuts price objective to $410.00 from $460.00
ALNY•Related News
NYLI CBRE Global Infrastructure Megatrends Term Fund flags July 2026 distribution at $0.125 per share
MEGI•
S&P 500 futures turn positive after June inflation data
SPY•
Belden partners with Tulip to link legacy factory equipment to real-time operations apps
BDC•
FuelCell Energy Inc <FCEL.O>: UBS Raises to Buy From Neutral; Raises Target Price to $27 From $22
FCEL•
Nexxen report flags “news-avoiding voters” as key 2026 midterm ad target
NEXN•